CCL2 and COVID-19: Patients with severe COVID-19 exhibit higher levels of pro-inflammatory cytokines (such as IL-6 and IL-8) in their bronchoalveolar lavage fluid as well as increased expression of inflammatory chemokines (such as CCL2) in macrophages compared to those with mild COVID-19 [19].